se ha leído el artículo
array:24 [ "pii" => "S1578219014000729" "issn" => "15782190" "doi" => "10.1016/j.adengl.2013.11.003" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "928" "copyright" => "Elsevier España, S.L. and AEDV" "copyrightAnyo" => "2013" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2014;105:e18-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2364 "formatos" => array:3 [ "EPUB" => 49 "HTML" => 1647 "PDF" => 668 ] ] "Traduccion" => array:1 [ "es" => array:19 [ "pii" => "S0001731013004031" "issn" => "00017310" "doi" => "10.1016/j.ad.2013.11.004" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "928" "copyright" => "Elsevier España, S.L. y AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2014;105:e18-21" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 4719 "formatos" => array:3 [ "EPUB" => 2 "HTML" => 2883 "PDF" => 1834 ] ] "es" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Caso clínico</span>" "titulo" => "Vendajes húmedos: nuestra experiencia" "tienePdf" => "es" "tieneTextoCompleto" => "es" "tieneResumen" => array:2 [ 0 => "es" 1 => "en" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e18" "paginaFinal" => "e21" ] ] "titulosAlternativos" => array:1 [ "en" => array:1 [ "titulo" => "Our Experience With Wet-Wrap Treatment" ] ] "contieneResumen" => array:2 [ "es" => true "en" => true ] "contieneTextoCompleto" => array:1 [ "es" => true ] "contienePdf" => array:1 [ "es" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figura 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 948 "Ancho" => 950 "Tamanyo" => 179793 ] ] "descripcion" => array:1 [ "es" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Imagen de la espalda del paciente número 6. Lesiones pretratamiento (arriba) y postratamiento (abajo).</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "C. Albarrán-Planelles, D. Jiménez-Gallo, M. Linares-Barrios, A. Martínez-Rodríguez" "autores" => array:4 [ 0 => array:2 [ "nombre" => "C." "apellidos" => "Albarrán-Planelles" ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Jiménez-Gallo" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Linares-Barrios" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martínez-Rodríguez" ] ] ] ] ] "idiomaDefecto" => "es" "Traduccion" => array:1 [ "en" => array:9 [ "pii" => "S1578219014000729" "doi" => "10.1016/j.adengl.2013.11.003" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "en" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219014000729?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731013004031?idApp=UINPBA000044" "url" => "/00017310/0000010500000003/v1_201404040105/S0001731013004031/v1_201404040105/es/main.assets" ] ] "itemSiguiente" => array:19 [ "pii" => "S1578219014000559" "issn" => "15782190" "doi" => "10.1016/j.adengl.2013.11.002" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "912" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "cor" "cita" => "Actas Dermosifiliogr. 2014;105:305-6" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 1834 "formatos" => array:3 [ "EPUB" => 46 "HTML" => 1471 "PDF" => 317 ] ] "en" => array:11 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Cases for Diagnosis</span>" "titulo" => "Plaque on the Nose" "tienePdf" => "en" "tieneTextoCompleto" => "en" "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "305" "paginaFinal" => "306" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Placa en la nariz" ] ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:6 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 404 "Ancho" => 575 "Tamanyo" => 51758 ] ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "B. de Unamuno-Bustos, R. Ballester-Sánchez, V. Alegre de Miquel" "autores" => array:3 [ 0 => array:2 [ "nombre" => "B." "apellidos" => "de Unamuno-Bustos" ] 1 => array:2 [ "nombre" => "R." "apellidos" => "Ballester-Sánchez" ] 2 => array:2 [ "nombre" => "V." "apellidos" => "Alegre de Miquel" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731013003724" "doi" => "10.1016/j.ad.2013.11.001" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731013003724?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219014000559?idApp=UINPBA000044" "url" => "/15782190/0000010500000003/v1_201404030048/S1578219014000559/v1_201404030048/en/main.assets" ] "itemAnterior" => array:19 [ "pii" => "S1578219014000547" "issn" => "15782190" "doi" => "10.1016/j.adengl.2013.02.019" "estado" => "S300" "fechaPublicacion" => "2014-04-01" "aid" => "827" "copyright" => "Elsevier España, S.L. and AEDV" "documento" => "simple-article" "crossmark" => 0 "subdocumento" => "crp" "cita" => "Actas Dermosifiliogr. 2014;105:e13-7" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:2 [ "total" => 2420 "formatos" => array:3 [ "EPUB" => 43 "HTML" => 1890 "PDF" => 487 ] ] "en" => array:13 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Reports</span>" "titulo" => "Clinical Usefulness of Reflectance Confocal Microscopy in the Management of Facial Lentigo Maligna Melanoma" "tienePdf" => "en" "tieneTextoCompleto" => "en" "tieneResumen" => array:2 [ 0 => "en" 1 => "es" ] "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e13" "paginaFinal" => "e17" ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Utilidad clínica de la microscopia confocal de reflectancia en el manejo del lentigo maligno melanoma" ] ] "contieneResumen" => array:2 [ "en" => true "es" => true ] "contieneTextoCompleto" => array:1 [ "en" => true ] "contienePdf" => array:1 [ "en" => true ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0015" "etiqueta" => "Figure 3" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr3.jpeg" "Alto" => 1246 "Ancho" => 1752 "Tamanyo" => 438425 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Case 3. A, Photograph and dermoscopic image showing pigmentation with a gray annular-granular pigmentation in area 1, a central papule in area 2, and incipient red rhomboidal structures at the bottom of area 3. B, Confocal submosaic (1000<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>500<span class="elsevierStyleHsp" style=""></span>μm) of the epidermis in area 1 showing a typical honeycomb pattern with isolated highly refractile cells without signs of atypia. C, Confocal submosaic (350<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>600<span class="elsevierStyleHsp" style=""></span>μm) of the epidermis in area 2 showing epithelial cords compatible with seborrheic keratosis. D, Confocal submosaic (800<span class="elsevierStyleHsp" style=""></span>×<span class="elsevierStyleHsp" style=""></span>900<span class="elsevierStyleHsp" style=""></span>μm) of the epidermis in area 3 showing a destructured honeycomb pattern (<span class="elsevierStyleInlineFigure"><elsevierMultimedia class="elsevierStyleLink" ident="fx9"></elsevierMultimedia></span>), perifollicular hyperpigmentation (<span class="elsevierStyleInlineFigure"><elsevierMultimedia class="elsevierStyleLink" ident="fx10"></elsevierMultimedia></span>), and multiple dendritic cells (<span class="elsevierStyleInlineFigure"><elsevierMultimedia class="elsevierStyleLink" ident="fx11"></elsevierMultimedia></span>) and dendritic pagetoid cells (<span class="elsevierStyleInlineFigure"><elsevierMultimedia class="elsevierStyleLink" ident="fx12"></elsevierMultimedia></span>) near the follicular openings. E, Histologic image (hematoxylin-eosin and HMB-45, original magnification ×<span class="elsevierStyleMonospace">1</span>0) showing a lentiginous epidermal pattern, with nests of atypical melanocytes in the basal layer of the epidermis and in the follicles (↓). HMB indicates human melanoma black.</p>" ] ] ] "autores" => array:1 [ 0 => array:2 [ "autoresLista" => "I. Alarcón, C. Carrera, S. Puig, J. Malvehy" "autores" => array:4 [ 0 => array:2 [ "nombre" => "I." "apellidos" => "Alarcón" ] 1 => array:2 [ "nombre" => "C." "apellidos" => "Carrera" ] 2 => array:2 [ "nombre" => "S." "apellidos" => "Puig" ] 3 => array:2 [ "nombre" => "J." "apellidos" => "Malvehy" ] ] ] ] ] "idiomaDefecto" => "en" "Traduccion" => array:1 [ "es" => array:9 [ "pii" => "S0001731013001105" "doi" => "10.1016/j.ad.2013.02.011" "estado" => "S300" "subdocumento" => "" "abierto" => array:3 [ "ES" => true "ES2" => true "LATM" => true ] "gratuito" => true "lecturas" => array:1 [ "total" => 0 ] "idiomaDefecto" => "es" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731013001105?idApp=UINPBA000044" ] ] "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219014000547?idApp=UINPBA000044" "url" => "/15782190/0000010500000003/v1_201404030048/S1578219014000547/v1_201404030048/en/main.assets" ] "en" => array:18 [ "idiomaDefecto" => true "cabecera" => "<span class="elsevierStyleTextfn">Case Reports</span>" "titulo" => "Our Experience With Wet-Wrap Treatment" "tieneTextoCompleto" => true "paginas" => array:1 [ 0 => array:2 [ "paginaInicial" => "e18" "paginaFinal" => "e21" ] ] "autores" => array:1 [ 0 => array:4 [ "autoresLista" => "C. Albarrán-Planelles, D. Jiménez-Gallo, M. Linares-Barrios, A. Martínez-Rodríguez" "autores" => array:4 [ 0 => array:4 [ "nombre" => "C." "apellidos" => "Albarrán-Planelles" "email" => array:1 [ 0 => "crisalbarran@hotmail.com" ] "referencia" => array:1 [ 0 => array:2 [ "etiqueta" => "<span class="elsevierStyleSup">¿</span>" "identificador" => "cor0005" ] ] ] 1 => array:2 [ "nombre" => "D." "apellidos" => "Jiménez-Gallo" ] 2 => array:2 [ "nombre" => "M." "apellidos" => "Linares-Barrios" ] 3 => array:2 [ "nombre" => "A." "apellidos" => "Martínez-Rodríguez" ] ] "afiliaciones" => array:1 [ 0 => array:2 [ "entidad" => "UGC de Dermatología Médico-Quirúrgica y Venereología, Hospital Universitario Puerta del Mar, Servicio Andaluz de Salud, Cádiz, Spain" "identificador" => "aff0005" ] ] "correspondencia" => array:1 [ 0 => array:3 [ "identificador" => "cor0005" "etiqueta" => "⁎" "correspondencia" => "Corresponding Author." ] ] ] ] "titulosAlternativos" => array:1 [ "es" => array:1 [ "titulo" => "Vendajes húmedos: nuestra experiencia" ] ] "resumenGrafico" => array:2 [ "original" => 0 "multimedia" => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 949 "Ancho" => 951 "Tamanyo" => 179208 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Clinical image of the back of patient number 6. Lesions before (top) and after (bottom) treatment.</p>" ] ] ] "textoCompleto" => "<span class="elsevierStyleSections"><span id="sec0005" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0025">Introduction</span><p id="par0005" class="elsevierStylePara elsevierViewall">Atopic dermatitis (AD) is a chronic eczematous dermatosis that causes pruritus; patients have a family history of allergic disease and the lesions arise at typical sites. AD causes considerable morbidity, such as difficulty in sleep initiation and maintenance, and also has an emotional impact on patients and their families.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,2</span></a></p><p id="par0010" class="elsevierStylePara elsevierViewall">There is an extensive therapeutic arsenal for the topical and systemic treatment of severe AD. The main systemic treatments include antihistamines, ciclosporin, glucocorticoids, azathioprine, methotrexate, mycophenolate mofetil, and omalizumab; in this context, most of these drugs must be prescribed for off-label use and have undesirable effects if treatment is continued for long periods. Wet-wrap treatment is a good alternative in patients in whom the aim is to avoid or reduce the dose of systemic treatments or their complications. To date, reports on the use of this therapy have mainly involved children, and the results have been very good, with few adverse effects; however, experience in adult patients is lacking.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3–5</span></a></p><p id="par0015" class="elsevierStylePara elsevierViewall">Wet-wrap treatment has been reported to be effective both in AD and in generalized dermatoses that cause pruritus, xerosis, and discomfort, such as nodular prurigo, psoriasis, and the erythrodermas.<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a></p></span><span id="sec0010" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0030">Case Descriptions</span><p id="par0020" class="elsevierStylePara elsevierViewall">We present our experience in 7 patients (6 men and 1 woman) aged between 16 and 80 years. The diagnoses were severe AD in 5 patients and nodular prurigo in 2; the conditions were resistant to conventional treatments. Wet-wrap was used in 6 patients in monotherapy and 1 patient was also administered daily pulses of 500<span class="elsevierStyleHsp" style=""></span>mg<span class="elsevierStyleHsp" style=""></span>of methylprednisolone for 3 days. In all cases, the wet-wrap treatment was performed during a hospital admission.</p><p id="par0025" class="elsevierStylePara elsevierViewall">The product applied was a mixture of a dilute topical corticosteroid (0.05% fluticasone) and an emollient (petrolatum-cetomacrogol).<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,6</span></a> All patients were treated for 7 days, with daily changes of the bandages.</p><p id="par0030" class="elsevierStylePara elsevierViewall">The application protocol was as follows: washing of the skin in the morning with warm water and mild soap. The dilute formulation of 0.05% fluticasone propionate, prepared in the hospital pharmacy, was then applied. The extemporaneous drug formulation consisted of 1 part of 0.05% fluticasone propionate cream in 9 parts of petrolatum with 20% cetomacrogol; the formulation was applied in the direction of hair growth. Between approximately 15 and 30<span class="elsevierStyleHsp" style=""></span>g of this formulation (depending on the body surface area treated) was applied to each patient each day.</p><p id="par0035" class="elsevierStylePara elsevierViewall">The following step consisted of cutting the tubular bandages (cotton wool-Tubifast) to fit the arms, legs, and trunk and moistening them in warm water. After moistening, these bandages were applied as the first layer of the wet-wrap. A second layer of dry tubular bandages was then fitted over the previous layer (<a class="elsevierStyleCrossRef" href="#fig0005">Fig. 1</a>). Every 2 to 3<span class="elsevierStyleHsp" style=""></span>hours the outer bandages must be removed in order to moisten the inner bandages using a warm-water spray. The solution should not be applied at night in order to allow the patient to sleep. This whole procedure is repeated daily for 7 days. Topical calcineurin inhibitors (tacrolimus, pimecrolimus) and topical low-strength corticosteroids were used on the face.</p><elsevierMultimedia ident="fig0005"></elsevierMultimedia><p id="par0040" class="elsevierStylePara elsevierViewall">None of the patients in our series developed any infectious skin disease (molluscum contagiosum, viral warts, impetigo, herpesvirus infection, or folliculitis) that would have required interruption of the treatment.</p><p id="par0045" class="elsevierStylePara elsevierViewall">The result on removal of the wet-wrap was a clinical improvement of the lesions in all cases (<a class="elsevierStyleCrossRef" href="#fig0010">Fig. 2</a>), with a marked reduction of pruritus and improvement in the health-related quality of life assessed using the SCORing Atopic Dermatitis (SCORAD) index (<a class="elsevierStyleCrossRef" href="#tbl0005">Table 1</a>). No adverse effects were observed except for a degree of discomfort due to the moisture of the internal bandages.</p><elsevierMultimedia ident="fig0010"></elsevierMultimedia><elsevierMultimedia ident="tbl0005"></elsevierMultimedia><p id="par0050" class="elsevierStylePara elsevierViewall">It is important to note that no washout period was used between treatments in the cases presented in our study and the therapy was not repeated in any of the patients. It is difficult to determine the period of remission that the wet-wraps achieved in our patients as all of them subsequently received systemic treatment, which interfered with the interpretation of results. However, this treatment produced an undeniable symptomatic improvement in all patients and achieved temporary remission of up to 30 days, increasing the efficacy of systemic treatments in previously refractory cases.</p></span><span id="sec0015" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0035">Discussion</span><p id="par0055" class="elsevierStylePara elsevierViewall">Wet-wrap or moist bandaging is defined as a treatment modality based on the use of a double layer of tubular bandages, the inner layer, closer to the skin, being moist; this can be combined with the application of emollient creams or creams containing active substances. The external layer of bandages is dry.</p><p id="par0060" class="elsevierStylePara elsevierViewall">This classic therapeutic modality was introduced in the United Kingdom in 1970 for the treatment of AD in children.<a class="elsevierStyleCrossRef" href="#bib0030"><span class="elsevierStyleSup">6</span></a> It subsequently started to be used in Germany, mainly in Munich and Hamburg. Currently, the center with greatest experience in the management of these bandages is the Sofia Pediatric Hospital in Rotterdam, Holland.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Several studies have been published on the use of these bandages. Dabade et al.,<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> in the Mayo Hospital in Minnesota, USA, achieved excellent results with this therapy in 218 patients with severe AD, all under 18 years of age. Improvement was observed in all the patients, and 93% of them presented an improvement of greater than 50%. Another example is the study performed by Bingham et al.,<a class="elsevierStyleCrossRef" href="#bib0005"><span class="elsevierStyleSup">1</span></a> also in the Mayo Hospital in Minnesota. Those authors treated 331 patients aged between 15 and 95 years. Interestingly, most of the patients in that latter study were adults with diagnoses that included inflammatory pruritic dermatoses such as AD, erythroderma, psoriasis, nodular prurigo, pityriasis rubra pilaris, dermatomyositis, and mycosis fungoides. The results in that study were also good, with improvement on the first day of treatment in 93.6%; only 1.7% reported no improvement in the pruritus during wet-wrap treatment.</p><p id="par0065" class="elsevierStylePara elsevierViewall">In recent years, wet-wrap treatment has come to be considered a safe and effective technique for severe childhood dermatitis.<a class="elsevierStyleCrossRef" href="#bib0040"><span class="elsevierStyleSup">8</span></a> This modality has also been used successfully in other indications, such as guttate psoriasis, psoriatic erythroderma, treatment-resistant pruritus, active urticaria pigmentosa, lamellar ichthyosis, and T-cell lymphoma.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,6</span></a> The technique may be effective in all dermatoses associated with pruritus, inflammation, and general discomfort.</p><p id="par0070" class="elsevierStylePara elsevierViewall">The mechanism of action that explains its efficacy is a recovery of the epidermal barrier by increasing the water content of the epidermis, decreasing transepidermal water loss, increasing the release of lamellar bodies, and restoring the laminar structure of the intercellular lipids.<a class="elsevierStyleCrossRef" href="#bib0025"><span class="elsevierStyleSup">5</span></a> Furthermore, this technique protects the skin from scratching and reduces pruritus and, through vasoconstriction secondary to cooling of the skin due to evaporation of the moisture, it reduces inflammation.<a class="elsevierStyleCrossRef" href="#bib0035"><span class="elsevierStyleSup">7</span></a> In addition, the absorption of topical corticosteroids is increased. Healing is further improved by the moist environment protected from external allergens. All this leads to a marked clinical improvement, evidenced by a significant reduction in the SCORAD index.</p><p id="par0075" class="elsevierStylePara elsevierViewall">The adverse effects of wet-wrap treatment are few and are not particularly serious. The most common is discomfort due to the limitation of mobility caused by the bandages, and shivering due to the moist inner bandages; this can be avoided by controlling the temperature of the water that is applied.<a class="elsevierStyleCrossRef" href="#bib0015"><span class="elsevierStyleSup">3</span></a> Other possible adverse effects are folliculitis secondary to the occlusive effect of the bandages; the risk can be reduced by applying the product in the direction of hair growth. Other more serious complications are skin infections due to <span class="elsevierStyleItalic">Pseudomonas</span> spp.; these are rare but can be favored by the moist environment created by these bandages. Cases of impetigo and herpesvirus infections have also been reported, and there are studies such as the one by Hindley et al.<a class="elsevierStyleCrossRef" href="#bib0045"><span class="elsevierStyleSup">9</span></a> that have demonstrated a higher incidence of these infections compared with nonocclusive therapies. However, it should be remembered that these infections are well-known problems associated with AD in childhood and are easily managed. If skin infection does occur, the wet-wrap therapy should be temporarily interrupted and appropriate treatment of the infection administered. Some authors have also considered there to be a relative contraindication to the use of these bandages in adolescents during puberty due to the risk of striae.<a class="elsevierStyleCrossRefs" href="#bib0015"><span class="elsevierStyleSup">3,6</span></a> We should also add that there are isolated case reports of suppression of the hypothalamic-hypophyseal-adrenal axis, with a fall in morning blood cortisol levels; this resolves within 2 weeks after treatment withdrawal.<a class="elsevierStyleCrossRefs" href="#bib0005"><span class="elsevierStyleSup">1,8</span></a> Given the low strength and concentration of the corticosteroid used, the treatment duration of less than 2 weeks, and the low possibility of absorption of the topical fluticasone, we did not measure the blood cortisol levels in our patients.</p><p id="par0080" class="elsevierStylePara elsevierViewall">In conclusion, we consider that wet-wrap therapy constitutes a safe and effective method for the treatment of severe or refractory AD in children and adults. Its advantages include a rapid response, reduced pruritus, and an improvement in the quality of sleep, as well as a reduction in the need for potentially dangerous systemic treatments. There is also a possibility for home treatment if the patients and family are adequately trained. The disadvantages of this method include the high cost, the need for trained staff, variable tolerance, and the adverse effects mentioned above.<a class="elsevierStyleCrossRefs" href="#bib0030"><span class="elsevierStyleSup">6,7</span></a></p><p id="par0085" class="elsevierStylePara elsevierViewall">For all these reasons, we believe wet-wrap therapy should be included as an option in the management of severe or refractory AD and other inflammatory dermatoses, both in children and in adults. Its main benefit is the rapid control of a flare-up that will enable us to consider new maintenance therapies.</p></span><span id="sec0020" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0040">Ethical Disclosures</span><span id="sec0025" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0045">Protection of human and animal subjects</span><p id="par0090" class="elsevierStylePara elsevierViewall">The authors declare that no experiments were performed on humans or animals for this investigation.</p></span><span id="sec0030" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0050">Confidentiality of data</span><p id="par0095" class="elsevierStylePara elsevierViewall">The authors declare that they have followed their hospital's protocol on the publication of patient data and that all patients included in the study received sufficient information and gave their written informed consent to participate in the study.</p></span><span id="sec0035" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0055">Right to privacy and informed consent</span><p id="par0100" class="elsevierStylePara elsevierViewall">The authors declare that no private patient data are disclosed in this article.</p></span></span><span id="sec0040" class="elsevierStyleSection elsevierViewall"><span class="elsevierStyleSectionTitle" id="sect0060">Conflicts of Interest</span><p id="par0105" class="elsevierStylePara elsevierViewall">The authors declare that they have no conflicts of interest.</p></span></span>" "textoCompletoSecciones" => array:1 [ "secciones" => array:10 [ 0 => array:2 [ "identificador" => "xres327182" "titulo" => "Abstract" ] 1 => array:2 [ "identificador" => "xpalclavsec308852" "titulo" => "Keywords" ] 2 => array:2 [ "identificador" => "xres327181" "titulo" => "Resumen" ] 3 => array:2 [ "identificador" => "xpalclavsec308851" "titulo" => "Palabras clave" ] 4 => array:2 [ "identificador" => "sec0005" "titulo" => "Introduction" ] 5 => array:2 [ "identificador" => "sec0010" "titulo" => "Case Descriptions" ] 6 => array:2 [ "identificador" => "sec0015" "titulo" => "Discussion" ] 7 => array:3 [ "identificador" => "sec0020" "titulo" => "Ethical Disclosures" "secciones" => array:3 [ 0 => array:2 [ "identificador" => "sec0025" "titulo" => "Protection of human and animal subjects" ] 1 => array:2 [ "identificador" => "sec0030" "titulo" => "Confidentiality of data" ] 2 => array:2 [ "identificador" => "sec0035" "titulo" => "Right to privacy and informed consent" ] ] ] 8 => array:2 [ "identificador" => "sec0040" "titulo" => "Conflicts of Interest" ] 9 => array:1 [ "titulo" => "References" ] ] ] "pdfFichero" => "main.pdf" "tienePdf" => true "PalabrasClave" => array:2 [ "en" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Keywords" "identificador" => "xpalclavsec308852" "palabras" => array:3 [ 0 => "Atopic dermatosis" 1 => "Wet-wrap dressing" 2 => "Corticosteroids" ] ] ] "es" => array:1 [ 0 => array:4 [ "clase" => "keyword" "titulo" => "Palabras clave" "identificador" => "xpalclavsec308851" "palabras" => array:3 [ 0 => "Dermatitis atópica" 1 => "Vendajes húmedos" 2 => "Corticosteroides" ] ] ] ] "tieneResumen" => true "resumen" => array:2 [ "en" => array:2 [ "titulo" => "Abstract" "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">A wide range of treatments are currently available for severe atopic dermatitis, including systemic therapies such as ciclosporin, corticosteroids, azathioprine, methotrexate, mofetil mycophenolate, and omalizumab. In patients who can no longer take systemic drugs or who need a dose reduction, wet-wrap treatment can be an excellent option.</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">To date, wet wraps have mostly been used in severe cases of childhood atopic dermatitis. We report our experience with wet-wrap treatment in 5 adults with atopic dermatitis and 2 with nodular prurigo. The results were satisfactory and there were few adverse effects.</p>" ] "es" => array:2 [ "titulo" => "Resumen" "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">En la actualidad disponemos de un importante arsenal terapéutico para la dermatitis atópica grave. Entre los tratamientos sistémicos cabe destacar entre otros la ciclosporina, los glucocorticoides, la azatioprina, el metotrexato, el mofetil micofenolato o el omalizumab. La terapia con vendajes húmedos oclusivos <span class="elsevierStyleItalic">(wet-wrap)</span> puede suponer una excelente alternativa en pacientes en los que se pretende evitar o reducir el uso de tratamientos sistémicos.</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Hasta el momento los vendajes húmedos se han considerado como una alternativa en los casos de dermatitis atópica grave de la infancia. Aportamos nuestra experiencia en un grupo de 7 pacientes adultos, 5 de ellos con dermatitis atópica y 2 con prurigo nodular, destacando los resultados satisfactorios obtenidos, así como los escasos efectos secundarios observados.</p>" ] ] "NotaPie" => array:1 [ 0 => array:2 [ "etiqueta" => "☆" "nota" => "<p class="elsevierStyleNotepara" id="npar0005">Please cite this article as: Albarrán-Planelles C, Jiménez-Gallo D, Linares-Barrios M, Martínez-Rodríguez A. Vendajes húmedos: nuestra experiencia. Actas Dermosifiliogr. 2014;105:e18–e21.</p>" ] ] "multimedia" => array:3 [ 0 => array:7 [ "identificador" => "fig0005" "etiqueta" => "Figure 1" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr1.jpeg" "Alto" => 1291 "Ancho" => 948 "Tamanyo" => 211667 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0025" class="elsevierStyleSimplePara elsevierViewall">Detail of the double layer of bandages employed.</p>" ] ] 1 => array:7 [ "identificador" => "fig0010" "etiqueta" => "Figure 2" "tipo" => "MULTIMEDIAFIGURA" "mostrarFloat" => true "mostrarDisplay" => false "figura" => array:1 [ 0 => array:4 [ "imagen" => "gr2.jpeg" "Alto" => 949 "Ancho" => 951 "Tamanyo" => 179208 ] ] "descripcion" => array:1 [ "en" => "<p id="spar0030" class="elsevierStyleSimplePara elsevierViewall">Clinical image of the back of patient number 6. Lesions before (top) and after (bottom) treatment.</p>" ] ] 2 => array:7 [ "identificador" => "tbl0005" "etiqueta" => "Table 1" "tipo" => "MULTIMEDIATABLA" "mostrarFloat" => true "mostrarDisplay" => false "tabla" => array:2 [ "leyenda" => "<p id="spar0040" class="elsevierStyleSimplePara elsevierViewall">Abbreviations: CS, corticosteroids; F, female; M, male; MTX, methotrexate; P, patient; SCORAD, SCORing Atopic Dermatitis; VAS, visual analogue scale<span class="elsevierStyleItalic">.</span></p>" "tablatextoimagen" => array:1 [ 0 => array:2 [ "tabla" => array:1 [ 0 => """ <table border="0" frame="\n \t\t\t\t\tvoid\n \t\t\t\t" class=""><thead title="thead"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Case \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Sex \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Age \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Diagnosis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Before Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">After Treatment \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Previous Treatments \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-head\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t" style="border-bottom: 2px solid black">Other Treatments During Hospitalization \t\t\t\t\t\t\n \t\t\t\t</td></tr></thead><tbody title="tbody"><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P1 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">69 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Atopic dermatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 61 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P2 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">F \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">62 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Nodular prurigo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VAS 10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VAS 6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS, ciclosporin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P3 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">21 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Atopic dermatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 53 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 14 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS, ciclosporin, ustekinumab, UV-B \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P4 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">16 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Atopic dermatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 69 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 10 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">29 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Atopic dermatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 71 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 25 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS, ciclosporin, omalizumab, MTX, UV-B \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P6 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">22 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Atopic dermatitis \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 66 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">SCORAD 11 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS, mycophenolate mofetil, UV-B, efalizumab \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Pulses of methylprednisolone \t\t\t\t\t\t\n \t\t\t\t</td></tr><tr title="table-row"><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">P7 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">M \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">80 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Nodular prurigo \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VAS 9 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">VAS 5 \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">Oral and topical CS, ciclosporin \t\t\t\t\t\t\n \t\t\t\t</td><td class="td" title="\n \t\t\t\t\ttable-entry\n \t\t\t\t " align="left" valign="\n \t\t\t\t\ttop\n \t\t\t\t">No \t\t\t\t\t\t\n \t\t\t\t</td></tr></tbody></table> """ ] "imagenFichero" => array:1 [ 0 => "xTab478873.png" ] ] ] ] "descripcion" => array:1 [ "en" => "<p id="spar0035" class="elsevierStyleSimplePara elsevierViewall">Variables Studied in Each Case and the Results Obtained on the SCORAD Index.</p>" ] ] ] "bibliografia" => array:2 [ "titulo" => "References" "seccion" => array:1 [ 0 => array:2 [ "identificador" => "bibs0005" "bibliografiaReferencia" => array:9 [ 0 => array:3 [ "identificador" => "bib0005" "etiqueta" => "1" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Wet dressings used with topical corticosteroids for pruritic dermatoses: A retrospective study" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:3 [ 0 => "L.G. Bingham" 1 => "J.W. Noble" 2 => "M.D. Davis" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2008.12.043" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2009" "volumen" => "60" "paginaInicial" => "792" "paginaFinal" => "800" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/19389521" "web" => "Medline" ] ] ] ] ] ] ] ] 1 => array:3 [ "identificador" => "bib0010" "etiqueta" => "2" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Impacto de la calidad de vida relacionada con la salud en población pediátrica y adulta española con dermatitis atópica. Estudio PSEDA" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J. Sánchez-Pérez" 1 => "E. Daudén-Tello" 2 => "A.M. Mora" 3 => "N. Lara" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.ad.2012.03.008" "Revista" => array:6 [ "tituloSerie" => "Actas Dermosifiliogr" "fecha" => "2013" "volumen" => "104" "paginaInicial" => "44" "paginaFinal" => "52" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22841507" "web" => "Medline" ] ] ] ] ] ] ] ] 2 => array:3 [ "identificador" => "bib0015" "etiqueta" => "3" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Wet-wrap treatment in children with atopic dermatitis: A practical guideline" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.C. Devillers" 1 => "A.P. Oranje" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1525-1470.2011.01691.x" "Revista" => array:6 [ "tituloSerie" => "Pediatr Dermatol" "fecha" => "2012" "volumen" => "29" "paginaInicial" => "24" "paginaFinal" => "27" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/22256990" "web" => "Medline" ] ] ] ] ] ] ] ] 3 => array:3 [ "identificador" => "bib0020" "etiqueta" => "4" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Occlusive therapy in atopic dermatitis: Overview" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "S.J. Braham" 1 => "R. Pugashetti" 2 => "J. Koo" 3 => "H.I. Maibach" ] ] ] ] ] "host" => array:1 [ 0 => array:1 [ "Revista" => array:5 [ "tituloSerie" => "J DermatologTreat" "fecha" => "2010" "volumen" => "21" "paginaInicial" => "62" "paginaFinal" => "72" ] ] ] ] ] ] 4 => array:3 [ "identificador" => "bib0025" "etiqueta" => "5" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "The effect of wet-wrap dressing on epidermal barrier in patients with atopic dermatitis" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "J.H. Lee" 1 => "S.J. Lee" 2 => "D. Kim" 3 => "D. Bang" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2007.02277.x" "Revista" => array:6 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2007" "volumen" => "21" "paginaInicial" => "1360" "paginaFinal" => "1368" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17958842" "web" => "Medline" ] ] ] ] ] ] ] ] 5 => array:3 [ "identificador" => "bib0030" "etiqueta" => "6" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Treatment of patients with atopic dermatitis using wet-wrap dressings with diluted steroids and/or emollients. An expert panel's opinion and review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "A.P. Oranje" 1 => "A.C. Devillers" 2 => "B. Kunz" 3 => "S.L. Jones" 4 => "L. de Raeve" 5 => "D. Van Gysel" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1468-3083.2006.01790.x" "Revista" => array:7 [ "tituloSerie" => "J Eur Acad Dermatol Venereol" "fecha" => "2006" "volumen" => "20" "paginaInicial" => "1277" "paginaFinal" => "1286" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/17062046" "web" => "Medline" ] ] "itemHostRev" => array:3 [ "pii" => "S009167491201202X" "estado" => "S300" "issn" => "00916749" ] ] ] ] ] ] ] 6 => array:3 [ "identificador" => "bib0035" "etiqueta" => "7" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Wet dressing therapy in conjunction with topical corticosteroids is effective for rapid control of severe pediatric atopic dermatitis: Experience with 218 patients over 30 years at Mayo Clinic" "autores" => array:1 [ 0 => array:2 [ "etal" => true "autores" => array:6 [ 0 => "T.S. Dabade" 1 => "D.M. Davis" 2 => "D.A. Wetter" 3 => "J.L. Hand" 4 => "M.T. McEvoy" 5 => "M.R. Pittelkow" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1016/j.jaad.2011.06.025" "Revista" => array:6 [ "tituloSerie" => "J Am Acad Dermatol" "fecha" => "2012" "volumen" => "67" "paginaInicial" => "100" "paginaFinal" => "106" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/21978575" "web" => "Medline" ] ] ] ] ] ] ] ] 7 => array:3 [ "identificador" => "bib0040" "etiqueta" => "8" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "Efficacy and safety of “wet-wrap” dressings as an intervention treatment in children with severe and/or refractory atopic dermatitis: a critical review of the literature" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:2 [ 0 => "A.C.A. Devillers" 1 => "A.P. Oranje" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1111/j.1365-2133.2006.07157.x" "Revista" => array:6 [ "tituloSerie" => "Br J Dermatol" "fecha" => "2006" "volumen" => "154" "paginaInicial" => "579" "paginaFinal" => "585" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16536797" "web" => "Medline" ] ] ] ] ] ] ] ] 8 => array:3 [ "identificador" => "bib0045" "etiqueta" => "9" "referencia" => array:1 [ 0 => array:2 [ "contribucion" => array:1 [ 0 => array:2 [ "titulo" => "A randomized study of “wet wraps” versus conventional treatment for atopic eczema" "autores" => array:1 [ 0 => array:2 [ "etal" => false "autores" => array:4 [ 0 => "D. Hindley" 1 => "G. Galloway" 2 => "J. Murray" 3 => "L. Gardener" ] ] ] ] ] "host" => array:1 [ 0 => array:2 [ "doi" => "10.1136/adc.2004.050831" "Revista" => array:6 [ "tituloSerie" => "Arch Dis Child" "fecha" => "2006" "volumen" => "91" "paginaInicial" => "164" "paginaFinal" => "168" "link" => array:1 [ 0 => array:2 [ "url" => "https://www.ncbi.nlm.nih.gov/pubmed/16308411" "web" => "Medline" ] ] ] ] ] ] ] ] ] ] ] ] ] "idiomaDefecto" => "en" "url" => "/15782190/0000010500000003/v1_201404030048/S1578219014000729/v1_201404030048/en/main.assets" "Apartado" => array:4 [ "identificador" => "6183" "tipo" => "SECCION" "en" => array:2 [ "titulo" => "Case Reports" "idiomaDefecto" => true ] "idiomaDefecto" => "en" ] "PDF" => "https://static.elsevier.es/multimedia/15782190/0000010500000003/v1_201404030048/S1578219014000729/v1_201404030048/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/" "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S1578219014000729?idApp=UINPBA000044" ]
año/Mes | Html | Total | |
---|---|---|---|
2024 Noviembre | 8 | 15 | 23 |
2024 Octubre | 88 | 37 | 125 |
2024 Septiembre | 97 | 24 | 121 |
2024 Agosto | 132 | 53 | 185 |
2024 Julio | 86 | 30 | 116 |
2024 Junio | 121 | 49 | 170 |
2024 Mayo | 94 | 37 | 131 |
2024 Abril | 97 | 26 | 123 |
2024 Marzo | 94 | 24 | 118 |
2024 Febrero | 82 | 27 | 109 |
2024 Enero | 94 | 31 | 125 |
2023 Diciembre | 77 | 12 | 89 |
2023 Noviembre | 94 | 27 | 121 |
2023 Octubre | 58 | 16 | 74 |
2023 Septiembre | 76 | 29 | 105 |
2023 Agosto | 63 | 24 | 87 |
2023 Julio | 121 | 45 | 166 |
2023 Junio | 76 | 25 | 101 |
2023 Mayo | 90 | 28 | 118 |
2023 Abril | 99 | 23 | 122 |
2023 Marzo | 79 | 26 | 105 |
2023 Febrero | 80 | 23 | 103 |
2023 Enero | 56 | 34 | 90 |
2022 Diciembre | 65 | 51 | 116 |
2022 Noviembre | 30 | 29 | 59 |
2022 Octubre | 28 | 18 | 46 |
2022 Septiembre | 24 | 44 | 68 |
2022 Agosto | 30 | 38 | 68 |
2022 Julio | 32 | 32 | 64 |
2022 Junio | 35 | 24 | 59 |
2022 Mayo | 95 | 49 | 144 |
2022 Abril | 115 | 63 | 178 |
2022 Marzo | 98 | 46 | 144 |
2022 Febrero | 102 | 32 | 134 |
2022 Enero | 128 | 45 | 173 |
2021 Diciembre | 83 | 48 | 131 |
2021 Noviembre | 97 | 56 | 153 |
2021 Octubre | 78 | 50 | 128 |
2021 Septiembre | 65 | 41 | 106 |
2021 Agosto | 69 | 42 | 111 |
2021 Julio | 67 | 32 | 99 |
2021 Junio | 60 | 41 | 101 |
2021 Mayo | 46 | 30 | 76 |
2021 Abril | 82 | 46 | 128 |
2021 Marzo | 62 | 29 | 91 |
2021 Febrero | 67 | 16 | 83 |
2021 Enero | 48 | 19 | 67 |
2020 Diciembre | 27 | 21 | 48 |
2020 Noviembre | 35 | 17 | 52 |
2020 Octubre | 37 | 16 | 53 |
2020 Septiembre | 42 | 20 | 62 |
2020 Agosto | 33 | 17 | 50 |
2020 Julio | 25 | 13 | 38 |
2020 Junio | 27 | 31 | 58 |
2020 Mayo | 26 | 28 | 54 |
2020 Abril | 33 | 23 | 56 |
2020 Marzo | 32 | 14 | 46 |
2020 Febrero | 4 | 1 | 5 |
2020 Enero | 0 | 6 | 6 |
2019 Diciembre | 4 | 10 | 14 |
2019 Noviembre | 0 | 6 | 6 |
2019 Octubre | 0 | 8 | 8 |
2019 Septiembre | 4 | 14 | 18 |
2019 Agosto | 0 | 7 | 7 |
2019 Julio | 0 | 19 | 19 |
2019 Junio | 2 | 16 | 18 |
2019 Mayo | 1 | 23 | 24 |
2019 Abril | 1 | 20 | 21 |
2019 Marzo | 2 | 11 | 13 |
2019 Febrero | 1 | 7 | 8 |
2019 Enero | 2 | 0 | 2 |
2018 Noviembre | 1 | 0 | 1 |
2018 Octubre | 3 | 0 | 3 |
2018 Septiembre | 3 | 0 | 3 |
2018 Junio | 0 | 3 | 3 |
2018 Mayo | 0 | 3 | 3 |
2018 Febrero | 32 | 5 | 37 |
2018 Enero | 41 | 12 | 53 |
2017 Diciembre | 41 | 5 | 46 |
2017 Noviembre | 41 | 7 | 48 |
2017 Octubre | 42 | 9 | 51 |
2017 Septiembre | 35 | 9 | 44 |
2017 Agosto | 45 | 15 | 60 |
2017 Julio | 35 | 13 | 48 |
2017 Junio | 48 | 23 | 71 |
2017 Mayo | 36 | 21 | 57 |
2017 Abril | 46 | 12 | 58 |
2017 Marzo | 30 | 51 | 81 |
2017 Febrero | 30 | 15 | 45 |
2017 Enero | 30 | 10 | 40 |
2016 Diciembre | 45 | 4 | 49 |
2016 Noviembre | 56 | 9 | 65 |
2016 Octubre | 59 | 23 | 82 |
2016 Septiembre | 75 | 6 | 81 |
2016 Agosto | 60 | 7 | 67 |
2016 Julio | 36 | 4 | 40 |
2016 Junio | 7 | 11 | 18 |
2016 Mayo | 10 | 9 | 19 |
2016 Abril | 13 | 2 | 15 |
2016 Marzo | 6 | 5 | 11 |
2016 Febrero | 9 | 2 | 11 |
2016 Enero | 12 | 6 | 18 |
2015 Diciembre | 13 | 3 | 16 |
2015 Noviembre | 12 | 1 | 13 |
2015 Octubre | 7 | 2 | 9 |
2015 Septiembre | 7 | 0 | 7 |
2015 Agosto | 4 | 4 | 8 |
2015 Julio | 43 | 9 | 52 |
2015 Junio | 42 | 4 | 46 |
2015 Mayo | 62 | 12 | 74 |
2015 Abril | 36 | 10 | 46 |
2015 Marzo | 27 | 5 | 32 |
2015 Febrero | 43 | 9 | 52 |
2015 Enero | 53 | 9 | 62 |
2014 Diciembre | 30 | 10 | 40 |
2014 Noviembre | 38 | 22 | 60 |
2014 Octubre | 41 | 15 | 56 |
2014 Septiembre | 44 | 28 | 72 |
2014 Agosto | 42 | 29 | 71 |
2014 Julio | 45 | 21 | 66 |
2014 Junio | 36 | 7 | 43 |
2014 Mayo | 53 | 11 | 64 |
2014 Abril | 24 | 8 | 32 |